0       0

AST 2014 - Cutting Edge of Transplantation


FR01f - The Challenge of Translation: One Donor - Many Organs, Regulations and Policies


Feb 14, 2014 9:45am ‐ Feb 14, 2014 10:15am

Description

Interventions aimed at ameliorating early organ injury thereby improving early organ function face unique challenges in translation, including clinical trial design and the extreme challenge of conducting trials in DBD (and DCD) donors as injury begins in the deceased donor. However, the administration of novel agents to deceased donors is fraught with ethical, logistical, and regulatory barriers that obstruct innovation. There is a broad-based effort involving HRSA, AST, ASTS, AOPO, and other major multi-disciplinary stakeholders to identify, discuss, and potentially resolve the key barriers.

Speaker(s):

  • Sandy Feng, MD, PhD, Univ of California, San Francisco

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content